Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)

Sponsor
GEM Hospital & Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT02081131
Collaborator
(none)
64
1
2
24
2.7

Study Details

Study Description

Brief Summary

The aim of this study is to compare the two surgical approaches namely laparoscopic pancreatoduodenectomy and open pancreatoduodenectomy for management of periampullary and pancreatic head cancers in terms of parameters like hospital stay, pathological radicality, complication rate, peri-operative and post operative outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Open surgery
  • Procedure: Laparoscopic surgery
N/A

Detailed Description

Laparoscopic pancreatoduodenectomy (LPD) although technically difficult, requiring high degree of expertise, has shown equal efficacy in terms of complications, oncological safety & overall outcome to that of open pancreatoduodenectomy (OPD) with advantages of minimally invasive surgery like decreased blood loss, reduced pain, shorter hospital stay & early return to work.

Although current literature from various centres supports its use, the studies done so far are, case comparisons of either small sample of population or non-randomized trials. According to our knowledge, a randomized trial analyzing open versus laparoscopic pancreatoduodenectomy (PD) in terms of complications and outcome, has not been reported. With this current study we will try to address this issue.

This study is a prospective, randomized, parallel group, controlled trail comparing laparoscopic versus open pancreatoduodenectomy in relation to the hospital stay, peri-operative parameters, pathological radicality & complications.

This is a single institute based trial, being conducted at GEM hospital and research center, Coimbatore, TN, India. The trial has been approved by the GEM Hospital ethical committee.

Through this trial we are planning to enroll patients having resectable periampullary and pancreatic head malignant lesion at diagnosis. After full assessment, optimization, approval of hospital tumor board with informed consent, those patients selected for surgical therapy with curative intention, will be randomized using computer generated random numbers either into Laparoscopic Pancreatoduodenectomy (LPD) group or Open Pancreatoduodenectomy (OPD) group.

The details of surgery, blood loss, operating time, conversion if any as well as details of postoperative events, hospital stay & complications if any will be recorded in proforma. Protocols for adjuvant therapy according to pathological stages will be followed. These patients will be reviewed at 1, 3 and 6 months post-surgery.

The primary outcome will be hospital stay at time of discharge or death. The secondary outcomes will be Blood Loss, Operating Time, Complications and pathological radicality at discharge or death. The trial is expected to last for a duration of 2 years.

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective Randomized Controlled Trial Comparing Laparoscopic Versus Open Pancreatoduodenectomy for Malignant Periampullary and Pancreatic Head Lesions
Study Start Date :
Sep 1, 2013
Actual Primary Completion Date :
Sep 1, 2015
Actual Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Laparoscopic Surgery

patients will be randomized to laparoscopic pancreatoduodenectomy group

Procedure: Laparoscopic surgery
laparoscopic pancreatoduodenectomy
Other Names:
  • laparoscopic pancreatoduodenectomy
  • whipple's operation
  • pylorus preserving pancreatoduodenectomy
  • Active Comparator: Open Surgery

    Patients will be randomized to Open pancreatoduodenectomy

    Procedure: Open surgery
    pancreatic head resection by open method
    Other Names:
  • Whipple's operation, pancreatoduodenectomy
  • Outcome Measures

    Primary Outcome Measures

    1. Hospital Stay [discharge from hospital or death which ever earlier recorded over 100 days from date of admission]

    Secondary Outcome Measures

    1. Blood loss [within 24 hours of primary surgical procedure]

      Blood loss at surgery

    2. Pathological radicality [within 7 days of surgery]

      Two specimen arms will be compared on the basis of extent of pathological clearance like margin positivity rate, number of lymph nodes, average length of surgical margin

    3. Operating time [At completion of the primary surgical procedure, recorded over 48 hrs]

      Time calculated in minutes

    4. Complication rate [100 days from date of surgery]

      Pancreatic surgery specific complications will be accessed by International Study group for pancreatic surgery ( ISGPS) classification like post operative pancreatic fistula ( POPF). Other complications will be accessed by Clavien Dindo Classification system

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adult males or females with a diagnosis of either of resectable Periampullary and pancreatic head cancers with
    1. No evidence of metastasis

    2. Radiological non-involvement of Superior Mesenteric Vein & Portal Vein

    3. Preserved fat planes between celiac axis, Hepatic Artery & Superior Mesenteric Artery

    Exclusion Criteria:
    1. Unresectable Tumor at surgery

    2. Pancreatoduodenectomy for other diagnosis like cystic tumors or chronic calcific pancreatitis with head mass

    3. With prior Neoadjuvant treatment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Gem Hospital & Research Centre Private Limited Coimbatore Tamil Nadu India 641045

    Sponsors and Collaborators

    • GEM Hospital & Research Center

    Investigators

    • Principal Investigator: Senthilnathan Palanisamy, MS, DNB, Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India
    • Study Director: Palanivelu Chinnusamy, MS, MCh, Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India
    • Study Director: Sandeep Sabnis, MS, Gem Hospital & Research Centre Private Limited, Coimbatore, Tamil Nadu, India

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    GEM Hospital & Research Center
    ClinicalTrials.gov Identifier:
    NCT02081131
    Other Study ID Numbers:
    • PLOT
    • CTRI/2013/09/004016
    First Posted:
    Mar 7, 2014
    Last Update Posted:
    Sep 15, 2015
    Last Verified:
    Sep 1, 2015
    Keywords provided by GEM Hospital & Research Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 15, 2015